Maladie rénale chronique (MRC) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, nécessitant une dialyse ou une transplantation rénale. Thérapie par cellules souches has emerged as a potential treatment option for late-stage CKD, offrir de l'espoir aux patients atteints de cette maladie débilitante.
Late-Stage Chronic Kidney Disease: Un aperçu
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. Cela peut provoquer toute une série de symptômes, y compris la fatigue, nausée, gonflement, and difficulty concentrating. À mesure que la maladie progresse, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Thérapie par cellules souches: A Potential Treatment Option
Stem cells are unspecialized cells that have the ability to differentiate into various cell types, y compris les cellules rénales. Researchers believe that thérapie par cellules souches could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
